August 9, 2016
FDA Warning Wire: Pfizer Hospira Plant Troubles
Slip-ups in a medical research firm's clinical investigation, air samples that tested positive for fungus at a compounding pharmacy and a popular skin care company's boasts all drew the U.S. Food and Drug Administration's ire in this week's batch of enforcement actions.
No comments:
Post a Comment